Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Beta Drugs IPO and Omfurn India IPO.
Beta Drugs IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Omfurn India IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| Beta Drugs IPO | Omfurn India IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt Ltd | Sarthi Capital Advisors Private Limited |
| Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹19.52 Cr whereas the issue size of the Omfurn India IPO is up to ₹4.17 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Omfurn India IPO is ₹23.00 per share.
| Beta Drugs IPO | Omfurn India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹23.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 6000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 22,96,000 shares | 18,12,000 shares |
| Issue Size Total (Amount) | up to ₹19.52 Cr | up to ₹4.17 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while Omfurn India IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and Omfurn India IPO is Oct 04, 2017, and Oct 05, 2017, respectively.
| Beta Drugs IPO | Omfurn India IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Sep 29, 2017 |
| Issue Close | Oct 04, 2017 | Oct 05, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to Omfurn India IPO P/E ratio of .
| Beta Drugs IPO | Omfurn India IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Beta Drugs IPO retail investors (RII) are offered while in Omfurn India IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Beta Drugs IPO and in Omfurn India IPO.
| Beta Drugs IPO | Omfurn India IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Beta Drugs IPO subscribed in total, whereas Omfurn India IPO subscribed .
| Beta Drugs IPO | Omfurn India IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
